Understanding Heparin-Induced Thrombocytopenia
Heparin-induced thrombocytopenia is a life-threatening complication arising from immune recognition of heparin–platelet factor 4 complexes. The condition manifests in two distinct forms:
- Type 1 HIT: A non-immunological, platelet-consuming process occurring within 24 hours of heparin exposure. Mild thrombocytopenia typically develops, with platelet counts rarely dropping below 100 × 10⁹/L. Prognosis is generally favourable, and the condition resolves with continued heparin use in most patients.
- Type 2 HIT: An antibody-mediated condition (anti-PF4/heparin) developing 5–10 days after heparin initiation (or earlier if prior exposure occurred). Severe thrombocytopenia (<50 × 10⁹/L) and thrombotic complications are characteristic. Without intervention, mortality and morbidity rates are substantial.
Early recognition is critical because continued heparin exposure perpetuates platelet activation and thrombosis propagation. The 4Ts score aids clinicians in rapidly identifying patients requiring urgent immunoassay testing and alternative anticoagulation.
The 4Ts Scoring System
The 4Ts score combines four clinical parameters, each rated on a point scale, to generate a composite risk assessment (range 0–8 points). Higher scores correlate with increased HIT probability and warrant confirmatory laboratory testing.
4Ts Score = Thrombocytopenia points + Timing points + Thrombosis points + Other causes points
Thrombocytopenia component:
2 points: Platelet fall >50% AND nadir ≥20 × 10⁹/L
1 point: Platelet fall 30–50% OR nadir 10–19.9 × 10⁹/L
0 points: Platelet fall <30% OR nadir <10 × 10⁹/L
Timing component:
2 points: Clear onset day 5–10 after heparin start
1 point: Non-clear onset day 5–10 OR onset day 1 with prior heparin exposure within 31–100 days
0 points: Onset <4 days without prior exposure OR onset >10 days
Thrombosis component:
2 points: New thrombosis, skin necrosis, or anaphylaxis
1 point: Recurrent/unconfirmed thrombosis
0 points: No thrombotic event
Other causes component:
2 points: No other cause evident
1 point: Possible alternative cause present
0 points: Definite alternative cause explaining thrombocytopenia
Thrombocytopenia— Percentage decline in platelet count and absolute nadir value during heparin exposureTiming— Number of days from heparin initiation to platelet count decline onsetThrombosis— New arterial or venous clotting events, skin manifestations, or systemic reactionsOther causes— Presence or absence of competing diagnoses (sepsis, DIC, chemotherapy, transfusion)
Platelet Nadir and Count Decline Calculation
Platelet nadir represents the lowest platelet concentration recorded during the period under evaluation. To identify nadir, review sequential platelet counts from baseline through the suspected HIT window and document the minimum value.
Platelet count fall percentage quantifies the magnitude of decline:
Platelet fall (%) = ((Baseline − Nadir) ÷ Baseline) × 100
For example, if a patient's baseline is 250 × 10⁹/L and nadir drops to 100 × 10⁹/L, the decline is ((250 − 100) ÷ 250) × 100 = 60%, meeting the 2-point criterion (>50% fall with nadir ≥20).
Accurate calculation demands careful attention to baseline timing—use the highest count prior to heparin exposure, not the count immediately after bolus administration.
Alternative Causes of Thrombocytopenia in Hospitalized Patients
The 'Other causes' component of the 4Ts score is critical for preventing false-positive scoring. Multiple conditions reduce platelet counts in acute care settings, potentially masking or mimicking HIT:
- Infectious: Sepsis, bacteremia, fungemia, ventilator-associated pneumonia
- Iatrogenic: Drug-induced thrombocytopenia (chemotherapy, antibiotics, NSAIDs), post-transfusion thrombocytopenia, dilutional thrombocytopenia from massive fluid resuscitation
- Coagulopathic: Disseminated intravascular coagulation (DIC), with concurrent consumption of platelets and clotting factors
- Post-operative: Thrombocytopenia within 72 hours of surgery due to haemodilution or splenic sequestration
- Immunological: Immune thrombocytopenia (ITP), systemic lupus erythematosus
If a definite alternative cause fully explains the platelet decline, score 0 points. If multiple potential causes exist, score 1 point. Only assign 2 points when HIT remains the sole plausible explanation.
Clinical Pearls and Common Pitfalls
Accurate 4Ts scoring depends on meticulous clinical data collection and recognition of edge cases.
- Baseline determination matters — Establish the true pre-heparin baseline platelet count, not the nadir after the bolus or first infusion. Heparin can trigger immediate, non-immune platelet sequestration (Type 1), which may obscure the baseline. Review counts from 24 hours before heparin initiation if available.
- Timing window can be ambiguous — When prior heparin exposure occurred months earlier or the exact date of onset is uncertain, apply clinical judgment and the 1-point criterion. Document the assumed timeline in the patient record to support reproducibility and decision-making by other team members.
- Thrombosis detection requires vigilance — Occult deep venous thrombosis and mesenteric ischaemia are easily missed in sedated or immobilised patients. A low clinical suspicion for HIT with a high 4Ts score should prompt duplex or imaging studies, especially if anticoagulation will be continued or switched.
- Repeat scoring when status changes — A single 4Ts assessment is a snapshot. Recalculate after new lab results, clinical events, or when the clinical picture shifts. A patient initially scoring 4 points may merit higher scrutiny if thrombosis develops or alternative diagnoses are ruled out.